Filing Details
- Accession Number:
- 0000899243-22-019219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-23 16:54:48
- Reporting Period:
- 2022-05-19
- Accepted Time:
- 2022-05-23 16:54:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750149 | Inhibikase Therapeutics Inc. | IKT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1272668 | Joseph Frattaroli | 3350 Riverwood Parkway Se, Suite 1900 Atlanta GA 30339 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-19 | 3,948 | $0.64 | 48,091 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
